Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00614432 · ClinicalTrials.gov registry record
Blood Loss at the Time of First Trimester Surgical Abortion in Anticoagulated Women
A clinical trial, sponsored by University of Hawaii.
- Completed
- Registry status
- 10
- Enrollment target
NCT00614432 is a clinical trial that has completed, run by University of Hawaii. The registered enrollment target is 10 participants.
The verdict
NCT00614432 has completed, sponsored by University of Hawaii.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The primary objective of this study is to compare blood loss resulting from surgical termination of pregnancy up to 12 weeks gestation between women who are anticoagulated to therapeutic levels and those who are not anticoagulated. This study is based on the hypothesis that anticoagulant therapy does not increase intraoperative blood loss in women receiving surgical abortions up to 12 weeks gestation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2008-01 |
| Est. Completion | 2010-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00614432
The ClinicalTrials.gov registry entry for NCT00614432 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Hawaii, which has 77 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00614432 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00614432 about?
NCT00614432 is a clinical study titled "Blood Loss at the Time of First Trimester Surgical Abortion in Anticoagulated Women". The primary objective of this study is to compare blood loss resulting from surgical termination of pregnancy up to 12 weeks gestation between women who are anticoagulated to therapeutic levels and those who are not anticoagulated. This study is based on the hypothesis that anticoagulant therapy doe...
What is the current status of trial NCT00614432?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2008-01. Estimated completion is 2010-04.
Who is sponsoring clinical trial NCT00614432?
This trial is sponsored by University of Hawaii, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.